We reported that retrodifferentiation of human tumour-derived hepatocytes into CSCs leads to an upregulated expression of pyruvate dehydrogenase kinase 4 (PDK4), which prevents pyruvate from feeding the tricarboxylic acid (TCA) cycle. This evidence concerns the gene PDK4 and neoplasm.